prohibitin-targeting peptide 1 targeting - AdipotidePeptidehow To use Prohibitin Prohibitin-Targeting Peptide 1: A Novel Approach to Obesity and Beyond

Adipotidepeptidedose Prohibitin-targeting peptide 1 (Prohibitin-TP01), also known by the developmental name Adipotide, represents a significant advancement in targeted therapeutic strategies. This innovative peptide is designed to selectively target specific blood vessels that supply adipose tissue, essentially starving fat cells of their blood supply. The mechanism of action involves causing these vessels to shrink, leading to a reduction in fat massA chimeric, 25-mer peptide that targets prohibitin, with potential antineoplastic activity. Prohibitin-targeting peptide 1 (prohibitin-TP01) consists of a fat- .... This approach holds considerable promise for the treatment of obesity and potentially other conditions linked to excessive adipose tissue.

The scientific exploration of prohibitin as a therapeutic target has revealed its crucial role in various cellular functions, including adipocyte (fat cell) function. Prohibitin-1 (PHB), a multifunctional protein, is expressed on the surface of adipose cells and is implicated in their normal development and maintenance. By developing a targeting peptide that specifically interacts with prohibitin, researchers have created a method to precisely deliver therapeutic agents to fat tissue.Study Details | NCT01262664 | A First-in-Man, Phase I ...

Prohibitin-targeting peptide 1 is described as a chimeric, 25-mer peptide that leverages this prohibitin interaction. Its development has been a multi-faceted endeavor, with various research groups contributing to its understanding and applicationProhibitin targeting peptide 1 - Drug Targets, Indications, .... For instance, studies have explored the use of prohibitin-binding peptide (PBP), an oligopeptide that targets prohibitin-rich adipose tissue, conjugated onto nanoparticles.Preventing diet-induced obesity in mice by adipose tissue ... Another notable sequence investigated is the CKGGRAKDC peptide, which also associates with prohibitin and has been established as a vascular marker for adipose tissue. This CKGGRAKDC (SEQ ID NO: 1) targeting peptide associates with prohibitin's role in adipose tissue targeting is a key area of research.

The therapeutic potential of Prohibitin-TP01 has been evaluated in pre-clinical models.The goal of this clinical research study is to find the highest tolerable dose ofPROHIBITIN-TP01that can be given to patients with advanced prostate cancer. In studies involving high-fat diet-induced obesity in mice, these peptides demonstrated a significant reduction in body weight. This suggests a paradigm shift in how obesity might be managed, moving towards targeted ablation of adipose tissue. The compound is designed to destroy white fat, the type of fat that accumulates around the abdomen and is often associated with metabolic health issues, particularly in men.

Beyond its anti-obesity applications, the unique targeting capabilities of Prohibitin-targeting peptide 1 have also led to its investigation in other areas. Early-stage clinical trials, such as a Phase I study, have explored the highest tolerable dose of PROHIBITIN-TP01 in patients with advanced prostate cancer and obesityProhibitin targeting peptide 1 - Drug Targets, Indications, .... This highlights the dual potential of the compound, addressing both a metabolic condition and a severe disease. The drug is also referred to as Adipotide, formerly known as Prohibitin-TP01, underscoring its evolving identity in the scientific and medical community.

The development of Prohibitin-TP01 is not limited to the peptide itself. Researchers have also explored nanotherapy approaches, such as prohibitin-targeted nanoparticles (PTNP), modified with a peptide ligand via a long PEG-linker. These nanocarriers can enhance the targeted accumulation of therapeutic agents. Furthermore, advancements include the creation of mixed-chirality prohibitin peptides, such as D-(RLARLAR)2, aiming for next-generation adipose-targeting prohibitin peptides capable of curbing adipocyte proliferation and function.作者：Z Gao·2021·被引用次数：18—Prohibitin-1 (PHB) is a multifunctional protein previously reported to be important for adipocyte function. PHB is expressed on the surface of adipose cells ...

The field is continuously evolving, with ongoing research into the precise mechanisms and broader applications of these targeting prohibitin peptides. The journey from initial discovery to potential clinical application involves rigorous scientific investigation, including understanding the metabolism of adipocytes and the role of prohibitin in various cellular processesPreventing diet-induced obesity in mice by adipose tissue .... The ultimate goal is to harness the power of targeted therapies like Prohibitin-targeting peptide 1 to address significant health challenges.